Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biomedical Research | 4 | 2025 | 559 | 1.300 |
Why?
|
| Authorship | 1 | 2025 | 30 | 0.890 |
Why?
|
| Physicians, Women | 1 | 2025 | 53 | 0.860 |
Why?
|
| Publishing | 1 | 2025 | 107 | 0.820 |
Why?
|
| Surgeons | 3 | 2023 | 289 | 0.800 |
Why?
|
| Academic Success | 1 | 2023 | 22 | 0.770 |
Why?
|
| General Surgery | 1 | 2025 | 225 | 0.750 |
Why?
|
| Periodicals as Topic | 1 | 2025 | 179 | 0.750 |
Why?
|
| Awards and Prizes | 1 | 2023 | 62 | 0.740 |
Why?
|
| Teratoma | 2 | 2023 | 121 | 0.340 |
Why?
|
| Pseudomonas Infections | 2 | 2023 | 116 | 0.330 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2023 | 136 | 0.270 |
Why?
|
| Biofilms | 2 | 2019 | 94 | 0.260 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 522 | 0.240 |
Why?
|
| Staphylococcus aureus | 3 | 2021 | 480 | 0.230 |
Why?
|
| Abortion, Legal | 1 | 2025 | 18 | 0.230 |
Why?
|
| Bibliometrics | 1 | 2025 | 38 | 0.220 |
Why?
|
| B-Cell Maturation Antigen | 1 | 2024 | 7 | 0.220 |
Why?
|
| Staphylococcal Infections | 2 | 2021 | 563 | 0.210 |
Why?
|
| Immunoconjugates | 1 | 2024 | 41 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 5 | 2023 | 982 | 0.200 |
Why?
|
| Gastroparesis | 1 | 2023 | 69 | 0.190 |
Why?
|
| Universities | 1 | 2023 | 123 | 0.190 |
Why?
|
| Multiple Myeloma | 1 | 2024 | 187 | 0.180 |
Why?
|
| Extracellular Traps | 2 | 2019 | 11 | 0.180 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2023 | 175 | 0.180 |
Why?
|
| Congenital Abnormalities | 1 | 2025 | 322 | 0.180 |
Why?
|
| Sex Factors | 1 | 2025 | 1334 | 0.170 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2021 | 230 | 0.170 |
Why?
|
| Hemolysin Proteins | 2 | 2018 | 29 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 493 | 0.160 |
Why?
|
| Pneumonia | 1 | 2023 | 338 | 0.160 |
Why?
|
| Neutrophils | 2 | 2019 | 358 | 0.160 |
Why?
|
| Cesarean Section | 1 | 2023 | 426 | 0.160 |
Why?
|
| Meningoencephalitis | 1 | 2019 | 19 | 0.150 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 383 | 0.140 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2018 | 37 | 0.140 |
Why?
|
| Implants, Experimental | 1 | 2017 | 4 | 0.130 |
Why?
|
| Pneumonia, Necrotizing | 1 | 2017 | 1 | 0.130 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 434 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 633 | 0.130 |
Why?
|
| Bacterial Toxins | 1 | 2018 | 170 | 0.130 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2018 | 140 | 0.130 |
Why?
|
| Arthritis, Infectious | 1 | 2017 | 66 | 0.120 |
Why?
|
| Rabbits | 3 | 2023 | 574 | 0.120 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2018 | 214 | 0.120 |
Why?
|
| Antibodies, Bacterial | 1 | 2017 | 412 | 0.110 |
Why?
|
| Cornea | 1 | 2019 | 561 | 0.110 |
Why?
|
| Osteomyelitis | 1 | 2017 | 210 | 0.110 |
Why?
|
| Wound Healing | 1 | 2018 | 476 | 0.100 |
Why?
|
| Humans | 13 | 2025 | 130372 | 0.100 |
Why?
|
| Male | 6 | 2025 | 64517 | 0.100 |
Why?
|
| Female | 6 | 2025 | 70274 | 0.100 |
Why?
|
| United States | 3 | 2023 | 11819 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 2545 | 0.080 |
Why?
|
| Animals | 8 | 2023 | 33924 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 1275 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 4664 | 0.060 |
Why?
|
| Hospital Charges | 1 | 2025 | 68 | 0.060 |
Why?
|
| Retreatment | 1 | 2024 | 87 | 0.050 |
Why?
|
| Maximum Tolerated Dose | 1 | 2024 | 174 | 0.050 |
Why?
|
| Tobramycin | 1 | 2023 | 22 | 0.050 |
Why?
|
| Myenteric Plexus | 1 | 2023 | 12 | 0.050 |
Why?
|
| Maternal Deprivation | 1 | 2023 | 13 | 0.050 |
Why?
|
| Sacrococcygeal Region | 1 | 2023 | 36 | 0.050 |
Why?
|
| Gastric Emptying | 1 | 2023 | 78 | 0.050 |
Why?
|
| Human papillomavirus 18 | 1 | 2023 | 12 | 0.050 |
Why?
|
| Financing, Organized | 1 | 2022 | 21 | 0.050 |
Why?
|
| Mice | 4 | 2023 | 18213 | 0.050 |
Why?
|
| Operative Time | 1 | 2023 | 199 | 0.050 |
Why?
|
| Human papillomavirus 16 | 1 | 2023 | 97 | 0.050 |
Why?
|
| Half-Life | 1 | 2022 | 150 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2023 | 129 | 0.040 |
Why?
|
| Primates | 1 | 2022 | 81 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2022 | 122 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2023 | 4701 | 0.040 |
Why?
|
| Papillomavirus Vaccines | 1 | 2023 | 110 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2025 | 8493 | 0.040 |
Why?
|
| Stomach | 1 | 2023 | 270 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2022 | 273 | 0.040 |
Why?
|
| Research Personnel | 1 | 2022 | 141 | 0.040 |
Why?
|
| Virulence | 1 | 2021 | 269 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 839 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2021 | 392 | 0.040 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 567 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2023 | 1018 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 216 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2021 | 180 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 147 | 0.040 |
Why?
|
| Length of Stay | 1 | 2025 | 1392 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 810 | 0.040 |
Why?
|
| Syndrome | 1 | 2021 | 1160 | 0.040 |
Why?
|
| Staphylococcal Vaccines | 1 | 2018 | 2 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2024 | 12855 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2018 | 31 | 0.030 |
Why?
|
| Titanium | 1 | 2017 | 26 | 0.030 |
Why?
|
| Financing, Government | 1 | 2017 | 33 | 0.030 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2017 | 17 | 0.030 |
Why?
|
| Ferrets | 1 | 2017 | 13 | 0.030 |
Why?
|
| Texas | 1 | 2025 | 3626 | 0.030 |
Why?
|
| Hospitalization | 1 | 2025 | 1927 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2025 | 17606 | 0.030 |
Why?
|
| Monocytes | 1 | 2018 | 336 | 0.030 |
Why?
|
| Forecasting | 1 | 2017 | 353 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 1167 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2018 | 405 | 0.030 |
Why?
|
| Skin | 1 | 2018 | 543 | 0.030 |
Why?
|
| Macrophages | 1 | 2018 | 654 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 6777 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 31117 | 0.020 |
Why?
|
| Pregnancy | 1 | 2023 | 7381 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 13269 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 20883 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 28370 | 0.010 |
Why?
|
| Child | 1 | 2021 | 26160 | 0.010 |
Why?
|